CPC C07D 471/14 (2013.01) [C07B 2200/13 (2013.01)] | 8 Claims |
1. A crystalline form of Compound (I):
![]() N-methyl-2-(4-methyl-1,4-diazepan-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carboxamide characterized by having a powder X-ray diffraction (PXRD) pattern peaks of 2-theta, at about 10.0° and 20.7°, the crystalline form being the crystalline Form 1.
|